More undeclared COIs of Luther Pendragon’s Simon Whale
(See 7th September piece on Whale’s role in the IMMDS Review looking at valproate (bipolar disorder, epilepsy), surgical mesh and Primodos)
‘Communications lead’ Whale failed to communicate to patient groups that his company Luther Pendragon actually started listing the IMMDS Review itself, for the March to May 2018 quarter, as a public relations client.
Patients were also not told that the pharmaceutical PLC Abbvie, and the medical imaging company Affidea, were clients in the same quarter. They did not appear in the June-August 2018 PR register.
Abbvie became notorious in early 2013 when it took legal action against the European Medicines Agency, to block publication of adverse drug events. It was successful for over a year. The APPC register only goes back to June 2013: it was a client of Luther Pendragon at that time.
Earlier this year, Abbvie unsuccessfully sued NHS England over a contract to provide Hepatitis C antivirals.
Undisclosed clients, and an undisclosed direct funder of a client, which gave evidence to the Review
The ‘June 2019 register of interests‘ which the IMMDS Review published shortly after my first August 14th piece on its ‘lead researcher’ Sonia Macleod, has not been further updated. It disclosed, for the first time, that NHS England, which gave evidence to the Review, was a Luther Pendragon client.
There are two other as yet undisclosed bodies which gave evidence to the Review. The Royal Pharmaceutical Society was not named in the Review ‘register’ as part-funding the Pharmacy APPG, which was a client until July 2019. The Professional Standards Authority is a current client.